Progyny financials
$24.79−2.86%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.29B | $1.17B | $1.09B | $786.9M | $500.6M | $344.9M | $229.7M |
| Gross profit | $304.5M | $253.4M | $238.8M | $167.3M | $112.1M | $70.1M | $45.5M |
| Gross margin | 23.6% | 21.7% | 21.9% | 21.3% | 22.4% | 20.3% | 19.8% |
| Operating income | $85.3M | $67.5M | $62.2M | $23.3M | $32.3M | $8.3M | $9.7M |
| Net income | $58.5M | $54.3M | $62.0M | $30.4M | $65.8M | $46.5M | -$8.6M |
| Net margin | 4.5% | 4.7% | 5.7% | 3.9% | 13.1% | 13.5% | −3.7% |
| Diluted EPS | $0.65 | $0.57 | $0.62 | $0.30 | $0.66 | $0.47 | $-0.41 |
| EBITDA | $90.2M | $70.6M | $64.5M | $24.9M | $33.6M | $10.3M | $11.8M |
| Operating cash flow | $210.2M | $179.1M | $188.8M | $80.4M | $26.0M | $36.2M | -$1.5M |
| Free cash flow | $191.8M | $173.7M | $185.2M | $77.2M | $23.9M | $35.2M | -$4.5M |
| Diluted shares | 89.9M | 95.4M | 100.7M | 100.0M | 100.4M | 99.1M | 20.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $112.2M | $162.3M | $97.3M | $120.1M | $91.4M | $70.3M |
| Short-term investments | $197.9M | $65.6M | $273.8M | $69.2M | $28.0M | $39.0M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $742.4M | $607.1M | $756.6M | $543.0M | $358.1M | $253.9M |
| Total liabilities | $226.4M | $185.0M | $203.2M | $166.0M | $106.2M | $87.0M |
| Shareholders' equity | $516.0M | $422.1M | $553.4M | $377.0M | $251.8M | $166.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology